NCT06156462View on ClinicalTrials.gov

A Study Evaluating the Use of ResAppDx v2.0 as an Aid to Diagnose Respiratory Disease in Adolescent and Adult Patients in an Emergency Department

CompletedOBSERVATIONAL

Enrollment

171

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

February 29, 2024

Study Completion Date

February 29, 2024

Conditions

Asthma ExacerbationCOPD ExacerbationLower Respiratory DiseasePneumonia

Interventions

DEVICE

ResAppDx v.20

Software device measuring cough sounds to aid diagnosis of respiratory diseases

Trial Locations (3)

Unknown

Addenbrookes Hospital, London

The Royal London Hospital, London

University College London Hospital, London

All Listed Sponsors

lead

ResApp Health Limited

INDUSTRY

NCT06156462 - A Study Evaluating the Use of ResAppDx v2.0 as an Aid to Diagnose Respiratory Disease in Adolescent and Adult Patients in an Emergency Department | Biotech Hunter | Biotech Hunter